Journal Information
Vol. 31. Issue 7.
Pages 371 (October 1995)
Vol. 31. Issue 7.
Pages 371 (October 1995)
Full text access
Riesgo de los glucocorticoides inhalados en el asma infantil
Visits
3570
P. Ferrer López
Departamento Médico. Laboratorios Fisons Ibérica. Zaragoza
This item has received
Article information
Full text is only aviable in PDF
Bibliografía
[1.]
E. González Pérez-Yarza.
Riesgo de los glucocorticoides inhalados en el asma infantil.
Arch Bronconeumol, 30 (1994), pp. 327-330
[2.]
P.J. Gergen, K.B. Weiss.
Epidemiology of asthma.
Asthma and rhinitis, pp. 15-31
[3.]
D.S. Robinson, Q. Hamid, S. Ying, A. Tsicopoulos, J. Barkans, A.M. Bentley.
Predominant Th2-like bronchoalveolar T-lyniphocyte population in atopic asthma.
N Engl J Med, 326 (1992), pp. 298-304
[4.]
G.A. Zieg, G. Lack, R.J. Harbeck, E.W. Gclfand, D.Y.M. Leung.
In vivo effects of glucocorticosteroids on IgE production.
J Allergy Clin Inintunol, 94 (1994), pp. 222-230
[5.]
H.G. Nüsslein, G. Wcber, J.R. Kalden.
Synthetic glucocorticoids potcntiate IgE synthesis. lnfluencc of stcroid and nonsteroid hormones on human in vitro IgE secretion.
Allergy, 49 (1994), pp. 365-370
[6.]
R.K.S. Loh, H.H. Jabara, R.S. Geha.
Disodium cromoglycate inhibits Sμ→SE deletional switch recombination and IgE synthesis in human B cells.
J Exp Med, 180 (1994), pp. 663-671
Copyright © 1995. Sociedad Española de Neumología y Cirugía Torácica